The University of Texas Medical Branch at Galveston
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Industries
N/A
Nr. of Employees
small (1-50)
The University of Texas Medical Branch at Galveston
The University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555
Expertise Areas
- Clinical trial management
- Real-world evidence and federated EHR-network research
- Animal models and in vivo assessment
- Mass spectrometry and proteomics
Key Technologies
- Flow cytometry
- Mass spectrometry
- Optical microscopy
- Microfluidic flow modeling
Key People
Antonio Bianco, MD, PhD
Vice President & Vice Provost, Research
Natalia Glubisz, MHA, CRA
Associate Vice President, Research Administration
Antonio Bianco, MD, PhD
Vice President & Vice Provost, Research
Natalia Glubisz, MHA, CRA
Associate Vice President, Research Administration
News & Updates
A new method of assessing patient blood by running it through a miniaturized device that mimics narrowed arteries could help doctors better understand a patient’s risk factors for developing blood clots in the arteries.
Research indicates that erectile dysfunction medications may significantly reduce the risk of death and cardiovascular diseases.
Funding awarded to study the role of extracellular vesicles in combating respiratory syncytial virus (RSV).
A study by UTMB’s Dr. Huey-Ming Tzeng found that a Medicare annual wellness visit was associated with greater recognition of mild cognitive impairment in older adults.
UTMB received a $46 million grant for research on vaccine development, highlighting the importance of funding research into viral threats.
Dr. Thomas Geisbert discusses the importance of understanding the genetic sequence of the virus spreading in Rwanda.
A new method of assessing patient blood by running it through a miniaturized device that mimics narrowed arteries could help doctors better understand a patient’s risk factors for developing blood clots in the arteries.
Research indicates that erectile dysfunction medications may significantly reduce the risk of death and cardiovascular diseases.
Funding awarded to study the role of extracellular vesicles in combating respiratory syncytial virus (RSV).
A study by UTMB’s Dr. Huey-Ming Tzeng found that a Medicare annual wellness visit was associated with greater recognition of mild cognitive impairment in older adults.
UTMB received a $46 million grant for research on vaccine development, highlighting the importance of funding research into viral threats.
Dr. Thomas Geisbert discusses the importance of understanding the genetic sequence of the virus spreading in Rwanda.